Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity

Front Oncol. 2021 Feb 3:11:650623. doi: 10.3389/fonc.2021.650623. eCollection 2021.

Abstract

[This corrects the article .].

Keywords: ALDH; PDX; bone metastasis; disulfiram; mTOR; prostate cancer.

Publication types

  • Published Erratum